| Literature DB >> 31223205 |
Langeswaran Kulanthaivel1, Jeyakanthan Jeyaraman2, Abir Biswas3, Gowtham Kumar Subbaraj4, S Santhoshkumar5.
Abstract
Staphylococcus aureus is an infectious agent that causes severe skin and soft tissue infection in hospitalized patients. Therefore, it is of interest to develop potent inhibitors for S. aureus. Penicillin Binding protein (PBP) is a known drug target for inhibition of cell wall biosynthesis in S. aureus. Hence, PBP was screened with compounds from six databases using virtual screening approaches. Results shows that the screened lead compound produced higher docking score (-9.87 kcal/mol) compared to resistant drugs. Antimicrobial activity using screened lead compounds and resistant drugs showed maximum activity in potential screened compounds compared to resistant compounds.Entities:
Keywords: Staphylococcus aureus; molecular docking; penicillin binding protein; virtual screening
Year: 2018 PMID: 31223205 PMCID: PMC6563657 DOI: 10.6026/97320630014471
Source DB: PubMed Journal: Bioinformation ISSN: 0973-2063
Glide score, glide energy of selected from virtual screening compounds
| S. No | Compound ID | Docking Score | Glide Energy | Glide e model |
| 1 | 742503(Specs) | -9.411 | 87.544 | -80.27 |
| 2 | 742505(Enamics database) | -8.002 | 73.452 | -80.27 |
| 3 | 00007(Maybridge c database) | -9.196 | 89.828 | -79.958 |
| 4 | 95911396 (ZINC Database) | -10.12 | 94.46 | -90.163 |
| 5 | 00004(TOSLAB) | -8.546 | 77.421 | -75.159 |
Glide score and glide energy of already reported ligands
| S. No | Compound id | Glide score | Glide energy |
| 1 | 2-deoxyglucose | -5.88 | 45.76 |
| 2 | Lonidamine | -6.33 | 52.82 |
| 3 | 3-bromopyruvate | -7.44 | 63.18 |
| 4 | Imatinib | -6.44 | 58.48 |
| 5 | Oxythiamine | -5.99 | 51.08 |
Predicted ADME properties of selected compounds through Qikprop analysis
| S. No. | Compound id | Molecular weight (g per mol)a | QP log P (o by w)b | QPPCacoc | QPLog HERG d | LogPMDCKe | Percentage of Human oral absorptionf |
| 1 | 742503 (Specs database) | 157.65 | 3.9 | 391.11 | -6.781 | 124.3 | 95.61 |
| 2 | 742505 (Enamics) | 476.81 | 4.87 | 535.24 | -6.879 | 152.216 | 67.485 |
| 3 | 00007 (Maybridge database) | 432.76 | 5.23 | 579.34 | -5.853 | 159.289 | 66.815 |
| 4 | 95911396 (ZINC Database) | 321.23 | 4.24 | 650.29 | -6.234 | 168.578 | 85.698 |
| 5 | 00004(TOSLAB) | 589.54 | 5.17 | 432.42 | -5.867 | 162.578 | 80.141 |
| aMolecular weight of the molecule. (Acceptable range 130.0-725.0.); bPredicted octanol/water partition coeffcient log P (acceptable range 2:0 to 6.5); cPredicted Caco-2 cell permeability in nm/s (acceptable range: less than 25 is poor and greater than 500 is great); dPredicted IC 50 value for blockage of HERG K+ channels (concern below -5:0); ePredicted apparent MDCK cell permeability in nm/s; fPercentage of human oral absorption (acceptable range: less than 25 percent is poor and greater than 80 percent is high) | |||||||
Figure 1Molecular dynamics simulation of selected compounds.
Figure 2Anti-microbial activity of selected compounds.
Antibacterial activity of selected compounds
| S. No | Compound Id | Diameter of inhibition zone (cm) |
| 1 | 742503 (Specs database) | 1.6 |
| 2 | 742505 (Enamics) | 1.8 |
| 3 | 00007 (Maybridge database) | 1.4 |
| 4 | 95911396 (ZINC Database) | 1.8 |
| 5 | 00004 (TOSLAB) | 1.5 |
MIC value of the Screened compounds
| S. No | Compound Id | MIC (micro g per ml) |
| 1 | 742503 (Specs database) | 9 |
| 2 | 742505 (Enamics) | 7 |
| 3 | 00007 (Maybridge database) | 8 |
| 4 | 95911396 (ZINC Database) | 2 |
| 5 | 00004(TOSLAB) | 4 |